Literature DB >> 2895150

2H1--a novel antigen involved in T lymphocyte triggering.

C Morimoto1, C E Rudd, N L Letvin, M Hagan, S F Schlossman.   

Abstract

A mAb anti-2H1, was produced against PHA-activated T cells from a lower primate, Aotus trivirgatus. Anti-2H1 reacted with 90% of peripheral T cells but was found to react with only 10% of thymocytes and some, but not all, leukemic T cell lines. 2H1 expression was dramatically increased when thymic cells were activated by Con A plus PMA. In contrast, anti-2H1 did not react with B cells, macrophages, null cells, or hematopoietic stem cell lines. More importantly, anti-2H1 antibody can induce T cell activation and proliferation in synergy with PMA or anti-T11(3). SDS-PAGE analysis of polypeptides immunoprecipitated with anti-2H1 showed two major polypeptides of 140 and 105 kDa. Thus, the 2H1 Ag can be distinguished from T3, T11, and 9.3 Ag. These results indicate that the 2H1 Ag appears to be involved in the activation of T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2895150

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Differentiation between MHC-restricted and non-MHC-restricted porcine cytolytic T lymphocytes.

Authors:  T Pauly; E Weiland; W Hirt; C Dreyer-Bux; S Maurer; A Summerfield; A Saalmüller
Journal:  Immunology       Date:  1996-06       Impact factor: 7.397

2.  Biochemical and functional characterization of 8-10C5 (gp120,90), a novel molecule on the surface of bovine T leucocytes.

Authors:  K L O'Reilly; G A Splitter
Journal:  Immunology       Date:  1990-11       Impact factor: 7.397

3.  Modulation of WC1, a lineage-specific cell surface molecule of gamma/delta T cells augments cellular proliferation.

Authors:  M D Hanby-Flarida; O J Trask; T J Yang; C L Baldwin
Journal:  Immunology       Date:  1996-05       Impact factor: 7.397

4.  Molecular linkage of the mouse CD5 and CD6 genes.

Authors:  O Lecomte; J B Bock; B W Birren; D Vollrath; J R Parnes
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

5.  CD6 recognizes the neural adhesion molecule BEN.

Authors:  J E Skonier; M A Bowen; A Aruffo; J Bajorath
Journal:  Protein Sci       Date:  1997-08       Impact factor: 6.725

Review 6.  Immunoregulatory T cell subsets and T cell activation in rheumatoid arthritis. A need for analysis on the clonal and molecular level.

Authors:  A Quayle; J Kjeldsen-Kragh; O Førre; K Waalen; M Sioud; C Kalvenes; J B Natvig
Journal:  Springer Semin Immunopathol       Date:  1989

7.  ALCAM (CD166) is involved in extravasation of monocytes rather than T cells across the blood-brain barrier.

Authors:  Ruth Lyck; Marc-André Lécuyer; Michael Abadier; Christof B Wyss; Christoph Matti; Maria Rosito; Gaby Enzmann; Thomas Zeis; Laure Michel; Ana B García Martín; Federica Sallusto; Fabien Gosselet; Urban Deutsch; Joshua A Weiner; Nicole Schaeren-Wiemers; Alexandre Prat; Britta Engelhardt
Journal:  J Cereb Blood Flow Metab       Date:  2016-11-14       Impact factor: 6.200

8.  Molecular model of the N-terminal receptor-binding domain of the human CD6 ligand ALCAM.

Authors:  J Bajorath; M A Bowen; A Aruffo
Journal:  Protein Sci       Date:  1995-08       Impact factor: 6.725

9.  Simultaneous cross-linking of CD6 and CD28 induces cell proliferation in resting T cells.

Authors:  L M Osorio; M Rottenberg; M Jondal; S C Chow
Journal:  Immunology       Date:  1998-03       Impact factor: 7.397

10.  A clinical exploratory study with itolizumab, an anti-CD6 monoclonal antibody, in patients with rheumatoid arthritis.

Authors:  Pedro C Rodriguez; Roberto Torres-Moya; Gil Reyes; Claudino Molinero; Dinorah Prada; Ana M Lopez; Isabel M Hernandez; Maria V Hernandez; Jose P Martinez; Xochel Hernandez; Angel Casaco; Mayra Ramos; Yisel Avila; Yinet Barrese; Enrique Montero; Patricia Hernandez
Journal:  Results Immunol       Date:  2012-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.